Skip to main content
Log in

Ventilator-assoziierte Pneumonien durch Pseudomonas aeruginosa

Antibiotikagabe: Wie kurz ist lang genug?

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Papazian L, Klompas M, Luyt CE. Ventilator-associated pneumonia in adults: a narrative review. Intensive. Care Med. 2020;46:888-906

  2. Albin OR, Kaye KS, McCreary EK et al. Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia. Clinical Infectious Diseases. 2022. https://doi.org/10.1093/cid/ciac784

  3. Tejerina E, Frutos-Vivar F, Restrepo MI et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care. 2006;21(1):56-65

  4. Lund-Palau H, Turnbull AR, Bush A et al. Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches. Expert Rev Respir Med. 2016;10(6):685-9

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Friedrich.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Friedrich, R., Rademacher, J. Antibiotikagabe: Wie kurz ist lang genug?. Pneumo News 15, 16–17 (2023). https://doi.org/10.1007/s15033-022-3463-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-022-3463-3

Navigation